HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eleftheria Hatzimichael Selected Research

Platinum

1/2012Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer.
5/2011Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eleftheria Hatzimichael Research Topics

Disease

19Neoplasms (Cancer)
08/2017 - 01/2010
13Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2021 - 02/2010
7B-Cell Lymphoma (Lymphoma, B Cell)
05/2022 - 09/2011
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 02/2010
6Multiple Myeloma
09/2018 - 12/2010
4Lymphoma (Lymphomas)
10/2020 - 08/2010
3Hodgkin Disease (Hodgkin's Disease)
07/2021 - 07/2013
3Iron Overload
06/2021 - 01/2010
3Hematologic Neoplasms (Hematological Malignancy)
01/2014 - 01/2013
2Thalassemia
06/2021 - 11/2016
2Chronic Disease (Chronic Diseases)
11/2016 - 01/2006
2Melanoma (Melanoma, Malignant)
07/2014 - 05/2013
2Carcinogenesis
01/2014 - 07/2013
2Bone Diseases (Bone Disease)
09/2012 - 06/2009
2Anemia
09/2012 - 07/2012
2Ovarian Neoplasms (Ovarian Cancer)
01/2012 - 05/2011
2Infections
09/2010 - 01/2007
2Leukemia
08/2010 - 02/2010
1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2022
1Hyperbilirubinemia
07/2021
1Intrahepatic Cholestasis
07/2021
1Hemolysis
06/2021
1Inappropriate ADH Syndrome (SIADH)
11/2020
1Hyponatremia
11/2020
1Wasting Syndrome (Wasting Disease)
11/2020
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2019
1Disease Progression
09/2018
1Hypercalcemia (Milk Alkali Syndrome)
11/2017
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
08/2017
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
08/2017
1Sitosterolemia
07/2017
1Cardiovascular Diseases (Cardiovascular Disease)
07/2017
1Dyslipidemias (Dyslipidemia)
07/2017
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2017
1Hemorrhage
01/2017
1Splenomegaly
11/2016
1Hyperplasia
11/2016
1Neutropenia
07/2016
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2015
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2014
1Lung Injury
07/2013
1Nevus (Nevi)
05/2013
1Pathologic Processes
03/2013

Drug/Important Bio-Agent (IBA)

10Azacitidine (5 Azacytidine)FDA Link
11/2021 - 01/2018
7Biomarkers (Surrogate Marker)IBA
07/2014 - 06/2009
4MicroRNAs (MicroRNA)IBA
01/2014 - 08/2011
3Rituximab (Mabthera)FDA Link
05/2022 - 08/2021
3IronIBA
06/2021 - 01/2004
3Lenalidomide (CC 5013)FDA Link
07/2016 - 03/2010
3Phosphotransferases (Kinase)IBA
01/2012 - 05/2011
2Brentuximab VedotinIBA
07/2021 - 10/2018
2Bleomycin (Blenoxane)FDA LinkGeneric
07/2021 - 07/2013
2GlobinsIBA
06/2021 - 11/2016
2HepcidinsIBA
06/2021 - 11/2016
2Proteins (Proteins, Gene)FDA Link
12/2014 - 05/2011
2DNA (Deoxyribonucleic Acid)IBA
07/2014 - 05/2013
2Biological ProductsIBA
07/2013 - 05/2011
2Serum AlbuminIBA
09/2012 - 07/2012
2PlatinumIBA
01/2012 - 05/2011
2Paclitaxel (Taxol)FDA LinkGeneric
01/2012 - 05/2011
2Pharmaceutical PreparationsIBA
01/2012 - 05/2011
1Monoclonal AntibodiesIBA
05/2022
1polatuzumab vedotinIBA
08/2021
1Bendamustine HydrochlorideFDA Link
08/2021
1Dacarbazine (DIC)FDA LinkGeneric
07/2021
1Vinblastine (Vinblastine Sulfate)FDA Link
07/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2021
1luspaterceptIBA
06/2021
1LigandsIBA
06/2021
1Vasopressins (Vasopressin)IBA
11/2020
1SaltsIBA
11/2020
1ElectrolytesIBA
11/2020
1Ferritins (Ferritin)IBA
01/2020
1CalciumIBA
11/2017
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2017
1Transcription Factors (Transcription Factor)IBA
08/2017
1Phytosterols (Plant Sterols)IBA
07/2017
1Inosine Triphosphate (ITP)IBA
01/2017
1Transferrin (beta 2 Transferrin)IBA
11/2016
1AntioxidantsIBA
11/2016
1Immunoglobulins (Immunoglobulin)IBA
10/2015
1QuercetinIBA
12/2014
1Immunomodulating AgentsIBA
07/2014
1Janus Kinase 2IBA
01/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2014
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2014
111- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
01/2014
1Polycomb-Group ProteinsIBA
01/2014
1tissue-factor-pathway inhibitor 2 (PP5)IBA
05/2013
1Histone Deacetylase InhibitorsIBA
01/2013
1Apoptosis Regulatory ProteinsIBA
09/2012
1Hemoglobins (Hemoglobin)IBA
09/2012
1Zoledronic Acid (Zometa)FDA Link
07/2012

Therapy/Procedure

10Therapeutics
10/2020 - 01/2006
4Drug Therapy (Chemotherapy)
01/2017 - 05/2011
2Radiotherapy
09/2021 - 01/2021
2Drug Tapering
01/2021 - 07/2016
1Erythrocyte Transfusion
06/2021
1Treatment Delay
01/2021
1Stem Cell Transplantation
10/2018